InspireMD, Inc. (NYSE:NSPR) has a beta value of 2.22 and has seen 1,968,054 shares traded in the recent trading session. The company, currently valued at $7.05 Million, closed the recent trade at $0.4607 per share which meant it lost $0 on the day or -5.98% during that session. The NSPR stock price is -1050.42% off its 52-week high price of $5.3 and 15.35% above the 52-week low of $0.39. If we look at the company’s 10-day average daily trading volume, we find that it stood at 6.11 Million shares traded. The 3-month trading volume is 3.63 Million shares.

The consensus among analysts is that InspireMD, Inc. (NSPR) is a Buy stock at the moment, with a recommendation rating of 0. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.35.

InspireMD, Inc. (NYSE:NSPR) trade information

Despite being -5.04% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Jun 25 when the NSPR stock price touched $0.587 or saw a rise of 20.2%. Year-to-date, InspireMD, Inc. shares have moved -56.63%, while the 5-day performance has seen it change -4.41%. Over the past 30 days, the shares of InspireMD, Inc. (NYSE:NSPR) have changed -44.26%. Short interest in the company has seen 1.69 Million shares shorted with days to cover at 0.47.

Wall Street analysts have a consensus price target for the stock at $2, which means that the shares’ value could jump 334.12% from current levels. The projected low price target is $2 while the price target rests at a high of $2. In that case, then, we find that the current price level is +334.12% off the targeted high while a plunge would see the stock lose 334.12% from current levels.

InspireMD, Inc. (NSPR) estimates and forecasts

Figures show that InspireMD, Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -49.48% over the past 6 months, with this year growth rate of -72.92%, compared to 2.5% for the industry. Other than that, the company has, however, increased its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are 78% and 77.8% for the next quarter. Revenue growth from the last financial year stood is estimated to be -54.3%.

1 analysts offering their estimates for the company have set an average revenue estimate of $200Million for the current quarter. 1 have an estimated revenue figure of $200Million for the next quarter concluding in September 01, 2020. Year-ago sales stood $1.35 Million for this quarter, and analysts expect sales will grow by -85.2% for the current quarter.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest +71.2% while over the next 5 years, the company’s earnings are expected to increase by 0%.